| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
562 |
| issn |
1448-0271
0310-057X |
| issueIdentifier |
6 |
| pageRange |
561-562 |
| publicationName |
Anaesthesia and Intensive Care |
| startingPage |
561 |
| bibliographicCitation |
Ho KM. Use of tramadol to attenuate severe dyskinesia in anti-N-methyl-D-aspartate receptor encephalitis. Anaesth Intensive Care. 2019 Nov;47(6):561–2. doi: 10.1177/0310057x19889369. PMID: 31829743. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6705-6004 |
| date |
201911 |
| identifier |
https://doi.org/10.1177/0310057x19889369
https://pubmed.ncbi.nlm.nih.gov/31829743 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1448-0271
https://portal.issn.org/resource/ISSN/0310-057X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/513 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Use of tramadol to attenuate severe dyskinesia in anti-N-methyl-D-aspartate receptor encephalitis |
| discusses |
http://id.nlm.nih.gov/mesh/M0021764 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D060426Q000150
http://id.nlm.nih.gov/mesh/D014147Q000494
http://id.nlm.nih.gov/mesh/D020820Q000209
http://id.nlm.nih.gov/mesh/D020820Q000188 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D014147Q000008
http://id.nlm.nih.gov/mesh/D006801 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33741
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10647 |